已发表论文

微小 RNA-384 通过靶向 CDC42 抑制神经胶质瘤的增殖、迁移和侵袭

 

Authors Gu G, Wang L, Zhang J, Wang H, Tan T, Zhang G

Received 27 February 2018

Accepted for publication 18 April 2018

Published 16 July 2018 Volume 2018:11 Pages 4075—4085

DOI https://doi.org/10.2147/OTT.S166747

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Narasimha Reddy Parine

Peer reviewer comments 2

Editor who approved publication: Dr XuYu Yang

Background: Accumulative evidence indicated that microRNAs (miRNAs) play a critical role in carcinogenesis and biological behaviors of glioma. Further bio-molecular mechanisms of miRNAs in glioma cells remain largely unknown, which can contribute to novel therapeutic strategy. 
Methods: In the present study, we detected the expression level of miR-384 by RT-PCR and Western blot. Meanwhile, Gain and loss function assay of miR-384 by transfection of miR-384 mimics and inhibitor. Moreover, wild and mutant psiCHECK-2-CDC42-3’-UTR luciferase reporter vectors were constructed and transfected into glioma cells with miR-384 mimics or miR-NC.
Results: miR-384 was dramatically down-regulated in human glioma tissues. It was also demonstrated that miR-384 significantly inhibited proliferation, migration and invasion of glioma cells. Cell division cycle 42 (Cdc42) was a direct target of miR-384 according to results of RT-PCR and Western blotting.
Conclusion: Our research demonstrated that miR-384 exerted an inhibitory effect on proliferation, migration and invasion of glioma via suppressing the expression of CDC42 , meaning that miR-384 may be regarded as a potential target in the treatment of glioma.
Keywords: miR-384, CDC42, glioma, proliferation, invasion




Figure 5 miR-384 binding to CDC42-3′-UTR to inhibit glioma cells.